MDXH vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW
Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.
180 Life Sciences (NASDAQ:ATNFW) and MDxHealth (NASDAQ:MDXH) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.
180 Life Sciences has higher earnings, but lower revenue than MDxHealth.
In the previous week, MDxHealth had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for MDxHealth and 0 mentions for 180 Life Sciences. MDxHealth's average media sentiment score of 0.00 beat 180 Life Sciences' score of -1.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
MDxHealth received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
MDxHealth has a consensus target price of $28.33, suggesting a potential upside of 805.22%. Given 180 Life Sciences' higher possible upside, analysts clearly believe MDxHealth is more favorable than 180 Life Sciences.
Summary
MDxHealth beats 180 Life Sciences on 5 of the 6 factors compared between the two stocks.
Get MDxHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
MDxHealth Competitors List
Related Companies and Tools